These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 10084638)
21. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial. Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study. Madhusoodanan S; Brenner R; Suresh P; Concepcion NM; Florita CD; Menon G; Kaur A; Nunez G; Reddy H Ann Clin Psychiatry; 2000 Mar; 12(1):11-8. PubMed ID: 10798821 [TBL] [Abstract][Full Text] [Related]
23. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia. Kinon BJ; Roychowdhury SM; Milton DR; Hill AL J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Tohen M; Jacobs TG; Grundy SL; McElroy SL; Banov MC; Janicak PG; Sanger T; Risser R; Zhang F; Toma V; Francis J; Tollefson GD; Breier A Arch Gen Psychiatry; 2000 Sep; 57(9):841-9. PubMed ID: 10986547 [TBL] [Abstract][Full Text] [Related]
25. A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial. Berk M; Brook S; Trandafir AI Int Clin Psychopharmacol; 1999 May; 14(3):177-80. PubMed ID: 10435771 [TBL] [Abstract][Full Text] [Related]
26. [Olanzapine in the treatment of depressive disorders with psychotic symptoms]. Adli M; Rossius W; Bauer M Nervenarzt; 1999 Jan; 70(1):68-71. PubMed ID: 10087520 [TBL] [Abstract][Full Text] [Related]
27. Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study. Marangell LB; Johnson CR; Kertz B; Zboyan HA; Martinez JM J Clin Psychiatry; 2002 May; 63(5):391-5. PubMed ID: 12019662 [TBL] [Abstract][Full Text] [Related]
30. Olanzapine versus haloperidol treatment in first-episode psychosis. Sanger TM; Lieberman JA; Tohen M; Grundy S; Beasley C; Tollefson GD Am J Psychiatry; 1999 Jan; 156(1):79-87. PubMed ID: 9892301 [TBL] [Abstract][Full Text] [Related]
31. Olanzapine versus haloperidol in schizoaffective disorder, bipolar type. Tohen M; Zhang F; Keck PE; Feldman PD; Risser RC; Tran PV; Breier A J Affect Disord; 2001 Dec; 67(1-3):133-40. PubMed ID: 11869760 [TBL] [Abstract][Full Text] [Related]
32. A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia. Ho BC; Miller D; Nopoulos P; Andreasen NC J Clin Psychiatry; 1999 Oct; 60(10):658-63. PubMed ID: 10549681 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883 [TBL] [Abstract][Full Text] [Related]
34. Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial. Gomez JC; Crawford AM J Clin Psychiatry; 2001; 62 Suppl 2():6-11. PubMed ID: 11232753 [TBL] [Abstract][Full Text] [Related]
35. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268 [TBL] [Abstract][Full Text] [Related]
36. Influence of fluoxetine on olanzapine pharmacokinetics. Gossen D; de Suray JM; Vandenhende F; Onkelinx C; Gangji D AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620 [TBL] [Abstract][Full Text] [Related]
37. How long should patients with psychotic depression stay on the antipsychotic medication? Rothschild AJ; Duval SE J Clin Psychiatry; 2003 Apr; 64(4):390-6. PubMed ID: 12716238 [TBL] [Abstract][Full Text] [Related]
38. Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial. Hamilton SH; Revicki DA; Edgell ET; Genduso LA; Tollefson G Pharmacoeconomics; 1999 May; 15(5):469-80. PubMed ID: 10537964 [TBL] [Abstract][Full Text] [Related]
39. Olanzapine in the treatment of refractory migraine and chronic daily headache. Silberstein SD; Peres MF; Hopkins MM; Shechter AL; Young WB; Rozen TD Headache; 2002 Jun; 42(6):515-8. PubMed ID: 12167140 [TBL] [Abstract][Full Text] [Related]
40. Olanzapine in the treatment of psychotic depression. Malhi GS; Checkley SA Br J Psychiatry; 1999 May; 174():460. PubMed ID: 10616618 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]